This full-day conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are actively working to grow this new and exciting industry. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neurotechnology industry and the investment community.

Sessions will cover a range of technologies and market segments in the neuro space, including neuromodulation, neural prostheses, neurodiagnostics, and neurostimulation. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as cochlear implants, stroke rehabilitation devices, implanted pain stimulators, neural-computer interfaces, and advanced brain sensing technologies.

A morning panel discussion on the VC outlook for neurotechnology features representatives of some of the leading venture capital firms active in the neuro space. The panelists will discuss critical issues such as the relative strengths and weaknesses of devices and bio/pharma approaches to neurological disorders, the current investment climate in the neuro space, and key factors in obtaining funding for neurotechnology startups.

Two other morning panel discussions are devoted to market opportunities for neurostimulation and neurodiagnostics. An afternoon session is devoted to the topic of neurotech spinoffs and university/industry partnerships. Neurotech Business Report editors James Cavuoto, Warren Grill, and Glenn Cornett will moderate panel discussions. The forum will also feature presentations from several early-stage neurotechnology firms covering a range of product and technology areas.

A preliminary agenda for this year's event is available by clicking the link on the left. For a report on events and attendance at last year's event, click here:

http://www.neurotechreports.com/pages/NLF02report.html